Landscapes / Companies
Alcon Research not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 8 in all
Trials
3 active
14 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Nov 2026soonPhase 3 trial completes | |||
| Next date | Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Ocular Hyperemia | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2027Phase 1/2 trial completes | |||
| Next date | Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Neovascular Age-related Macular Degeneration (nAMD) | ||||
| Open drug page | |||||
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021